Company · CIK 0001281895 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
ROCKET PHARMACEUTICALS, INC. · RCKT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 SForm 4 → | Sep 15, 8:27 pm EDT | Martin WilsonGeneral Counsel | 75,364 | $3.40 | $256,464 | 598,489 | −11.2% | |
| Aug 18, 2026 SForm 4 → | Aug 20, 5:30 pm EDT | Martin WilsonGeneral Counsel | 631 | $3.38 | $2,133 | 673,853 | −0.09% | |
| Aug 18, 2026 SForm 4 → | Aug 20, 5:25 pm EDT | Gaurav ShahCEO | 2,293 | $3.38 | $7,753 | 1,056,594 | −0.22% | |
| Aug 13, 2026 SForm 4 → | Aug 17, 5:52 pm EDT | Gaurav ShahCEO | 2,837 | $3.38 | $9,592 | 1,058,887 | −0.27% | |
| Aug 13, 2026 SForm 4 → | Aug 17, 5:50 pm EDT | Martin WilsonGeneral Counsel | 3,493 | $3.38 | $11,810 | 674,484 | −0.52% | |
| Aug 11, 2026 SForm 4 → | Aug 13, 4:15 pm EDT | Christopher James StevensChief Operating Officer | 36,658 | $3.50 | $128,266 | 505,784 | −6.76% | |
| Aug 11, 2026 SForm 4 → | Aug 13, 4:15 pm EDT | Sarbani ChaudhuriSee Remarks | 4,701 | $3.50 | $16,449 | 262,809 | −1.76% | |
| Aug 3, 2026 AForm 4 → | Aug 5, 8:49 pm EDT | Christopher James StevensChief Operating Officer | 73,313 | — | — | 542,442 | — | |
| Aug 3, 2026 JForm 4 → | Aug 5, 8:45 pm EDT | David P SouthwellDirector | 150,000 | — | — | 204,522 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 AForm 4 → | Aug 5, 8:49 pm EDT | Christopher James StevensChief Operating Officer | 101,428 | — | — | 101,428 | — |